These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36278626)

  • 21. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
    Held PK; Shapira SK; Hinton CF; Jones E; Hannon WH; Ojodu J
    Mol Genet Metab; 2015 Nov; 116(3):133-8. PubMed ID: 26296712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a pitfall in congenital adrenal hyperplasia newborn screening: evidence of maternal use of corticoids detected on dried blood spot.
    Houang M; Nguyen-Khoa T; Eguether T; Ribault B; Brabant S; Polak M; Netchine I; Lamazière A
    Endocr Connect; 2022 Jun; 11(6):. PubMed ID: 35521805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Newborn Screening Practices for the Early Detection of Congenital Adrenal Hyperplasia.
    Conlon TA; Hawkes CP; Brady JJ; Loeber JG; Murphy N
    Horm Res Paediatr; 2024; 97(2):113-125. PubMed ID: 37231960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
    Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for congenital adrenal hyperplasia in New York State.
    Pearce M; DeMartino L; McMahon R; Hamel R; Maloney B; Stansfield DM; McGrath EC; Occhionero A; Gearhart A; Caggana M; Tavakoli NP
    Mol Genet Metab Rep; 2016 Jun; 7():1-7. PubMed ID: 27331001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn screening for congenital adrenal hyperplasia.
    Therrell BL
    Endocrinol Metab Clin North Am; 2001 Mar; 30(1):15-30. PubMed ID: 11344933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital adrenal hyperplasia and the second newborn screen.
    Chan CL; McFann K; Taylor L; Wright D; Zeitler PS; Barker JM
    J Pediatr; 2013 Jul; 163(1):109-13.e1. PubMed ID: 23414665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal screening for congenital adrenal hyperplasia.
    White PC
    Nat Rev Endocrinol; 2009 Sep; 5(9):490-8. PubMed ID: 19690561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Steroid Profiling by Liquid Chromatography-Tandem Mass Spectrometry for the Rapid Confirmation and Early Treatment of Congenital Adrenal Hyperplasia: A Neonatal Case Report.
    Cicalini I; Tumini S; Guidone PI; Pieragostino D; Zucchelli M; Franchi S; Lisi G; Lelli Chiesa P; Stuppia L; Laurenzi V; Rossi C
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31766536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia.
    Lasarev MR; Bialk ER; Allen DB; Held PK
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32525982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
    Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
    Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia.
    Pode-Shakked N; Blau A; Pode-Shakked B; Tiosano D; Weintrob N; Eyal O; Zung A; Levy-Khademi F; Tenenbaum-Rakover Y; Zangen D; Gillis D; Pinhas-Hamiel O; Loewenthal N; de Vries L; Landau Z; Rachmiel M; Abu-Libdeh A; Eliakim A; Strich D; Koren I; German A; Sack J; Almashanu S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3172-3180. PubMed ID: 30865229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia.
    Navardauskaitė R; Banevičiūtė K; Songailienė J; Grigalionienė K; Čereškevičius D; Šukys M; Mockevicienė G; Smirnova M; Utkus A; Verkauskienė R
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
    Hikita Y
    Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):197-219. PubMed ID: 3874793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N; Doan LV; Connelly KJ; Denniston S; Willis S; LaFranchi SH
    Horm Res Paediatr; 2020; 93(2):128-136. PubMed ID: 32659761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency.
    Kösel S; Burggraf S; Fingerhut R; Dörr HG; Roscher AA; Olgemöller B
    Clin Chem; 2005 Feb; 51(2):298-304. PubMed ID: 15608154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.